Equibles does not estimate personal net worth.
Get an email with a short summary when InfuSystem Holdings, Inc publishes a filing, an earnings call transcript or a press release.
Get INFU alertsCarrie Lachance is recorded as COO, Board Member and CEO at InfuSystem Holdings, Inc (INFU). The newest filing on record that lists Carrie Lachance as Board Member and CEO at InfuSystem Holdings, Inc (INFU) is dated April 10, 2026. The newest filing on record that lists Carrie Lachance as COO at InfuSystem Holdings, Inc (INFU) is dated April 10, 2025. InfuSystem Holdings, Inc reported in an 8-K filed May 12, 2026 that Carrie Lachance was appointed Director, effective May 11, 2026. InfuSystem Holdings, Inc reported in an 8-K filed June 3, 2025 that Carrie Lachance was appointed member of the Board, effective May 19, 2025. InfuSystem Holdings, Inc reported in an 8-K filed June 3, 2025 that Carrie Lachance was appointed President and Chief Executive Officer, effective May 19, 2025. Equibles holds 5 filed executive changes naming Carrie Lachance; each is listed under recent activity with its source filing. The proxy statement of InfuSystem Holdings, Inc reports total compensation of $2,911,783 for Carrie Lachance in fiscal 2025, including a base salary of $478,887. Disclosed compensation is on record for 6 fiscal years. Carrie Lachance has spoken on 19 earnings calls across 1 company, most recently for InfuSystem Holdings, Inc on August 4, 2026. InfuSystem Holdings, Inc is classified in the Medical Devices industry within the Healthcare sector. Other leadership on record at InfuSystem Holdings, Inc includes Richard DiIorio (CEO), Beverly Huss (Chairman and Board Member), Ronald Hundzinski (Chairman) and 7 others.
“All seven of the Company's Board nominees (Drs Eichenbaum and Sviokla, Messrs. Gendron, Hundzkinski, and Shuda and Mses. Huss and Lachance) were elected to the Board.”
“As of the Effective Date, pursuant to stockholder vote at the 2025 annual meeting, Employee was retained as a member of the Board.”
“I will provide a second quarter overview, highlighting our progress in the quarter, then Barry will provide a detailed summary of our financial results. I will then come back with some closing comments before opening the line to questions.”
“I will provide a first-quarter overview, highlighting key initiatives, and updating our progress on strategic priorities. Then Barry will provide a detailed summary of our financial results.”
“I will provide a fourth quarter overview, highlighting key initiatives, outlining our strategic priorities, and providing our outlook for 2026. Then Barry will provide a detailed summary of our financial results.”
“I will provide a third quarter overview, highlighting key successes, addressing notable challenges and outlining our strategic priorities as we wrap up 2025 and look forward to 2026.”
“I will provide a second quarter overview, highlighting key successes, addressing notable challenges and outlining our strategic priorities for the balance of the year and beyond.”
Start not stated–present
Last confirmed April 10, 2025
Start not stated–present
Last confirmed April 10, 2026
Start not stated–present
Last confirmed April 10, 2026
Proxy statement
Start not stated–2021-04-05
Last confirmed by a filing; no departure on record
Medical Devices · Healthcare
COO, Board Member, CEO
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | InfuSystem Holdings, Inc (INFU) | Chief Executive Officer | $478,887 | $2,911,783 |
| 2024 | InfuSystem Holdings, Inc (INFU) | President and Chief Operating Officer | $430,500 | $1,289,929 |
| 2023 | InfuSystem Holdings, Inc (INFU) | President and Chief Operating Officer | $410,000 | $1,264,258 |
| 2022 | InfuSystem Holdings, Inc (INFU) | President and Chief Operating Officer | $389,481 | $794,685 |
| 2021 | InfuSystem Holdings, Inc (INFU) | President and Chief Operating Officer | $315,000 | $2,359,497 |
| 2020 | InfuSystem Holdings, Inc (INFU) | President and Chief Operating Officer | $268,291 | $717,286 |
